Board of Directors

Naruhito Higo headshot
DR. NARUHITO HIGO

Board Chairman

Global Technology Development Officer
and Head of Quality Assurance
Hisamitsu
Pharmaceutical Co., Inc.

Masumoto 280x280
TAKESHI MASUMOTO

Vice Chairman

Chief Executive Officer
Noven Pharmaceuticals, Inc.

Noven Officers

TAKESHI MASUMOTO Headshot

TAKESHI MASUMOTO

Vice Chairman & Chief Executive Officer

JOHN CHOI Headshot

JOHN CHOI

Chief Administrative Officer and Chief Financial Officer

John Choi is Noven’s Chief Administrative Officer and Chief Financial Officer. Mr. Choi, who joined Noven in 2010, most recently served Noven as its Executive Director – Business Planning & Analysis. Prior to Noven, Mr. Choi served as Director of Commercial Operations & Planning for Ther-Rx (a branded pharmaceutical division of KV Pharmaceuticals). Previously, he served Abbott Laboratories in various positions in the manufacturing operations, cost accounting, finance, and international divisions, and served as an expatriate at Abbott’s Korean affiliate, where he held leadership roles in financial planning and analysis and other commercial leadership roles.

Fast Facts

Core Business:
Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.

Year of Incorporation:
1987

Employees:
Over 300

Board Member & Chief Executive Officer:
Takeshi Masumoto

Media, General Business
& Other Inquiries:

CorporateAffairs@noven.com

Partnering and Other Business Development Opportunities
Tel: 551-233-2700
BusDev@noven.com

Employment Inquiries:
Marilyn Reynaldo
Associate Director –
Talent Acquisition
mreynaldo@noven.com

Community Support:
Corporate Social Responsibility

Affiliated Companies:
Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.

Noven's commercialized products are marketed and sold through Noven Therapeutics, LLC.

Grove Pharmaceuticals is the generic division of Noven Therapeutics, LLC.